TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,753 | -42.4% | 18,205 | -1.0% | 0.00% | – |
| Q2 2023 | $282,347 | -21.2% | 18,382 | +15.4% | 0.00% | – |
| Q1 2023 | $358,266 | +1.2% | 15,930 | -5.4% | 0.00% | – |
| Q4 2022 | $353,998 | -56.1% | 16,833 | -48.6% | 0.00% | -100.0% |
| Q3 2022 | $807,000 | -46.3% | 32,747 | -47.2% | 0.00% | 0.0% |
| Q2 2022 | $1,504,000 | +565.5% | 62,045 | +753.8% | 0.00% | – |
| Q4 2021 | $226,000 | -18.4% | 7,267 | -36.5% | 0.00% | – |
| Q3 2021 | $277,000 | +42.8% | 11,442 | -14.0% | 0.00% | – |
| Q2 2021 | $194,000 | -66.4% | 13,298 | -42.5% | 0.00% | – |
| Q1 2021 | $577,000 | -7.7% | 23,113 | +0.9% | 0.00% | – |
| Q4 2020 | $625,000 | – | 22,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,370,000 | $113,203,200 | 5.24% |
| Finepoint Capital LP | 761,721 | $11,700,035 | 4.05% |
| Kynam Capital Management, LP | 1,454,730 | $22,344,653 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 441,019 | $6,769,642 | 2.06% |
| MPM BioImpact LLC | 552,846 | $8,491,715 | 1.71% |
| ARMISTICE CAPITAL, LLC | 7,450,000 | $114,432,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 435,313 | $6,686,408 | 1.12% |
| Octagon Capital Advisors LP | 495,000 | $7,603,200 | 1.06% |
| Orbimed Advisors | 2,118,100 | $32,534,016 | 0.59% |
| Rock Springs Capital Management LP | 1,527,720 | $23,465,779 | 0.56% |